Fusidate De Sodium Pierre Fabre (Sodium Fusidate)

Sodium fusidate works by inhibiting bacterial protein synthesis. It interferes with the function of elongation factor G (EF-G), which is essential for bacterial growth. This bacteriostatic effect prevents the bacteria from multiplying, allowing the body's immune system to eliminate the infection. The medication is applied topically to the affected area, where it exerts its antibacterial effects.

The usual dose of Fusidate De Sodium Pierre Fabre is determined by a healthcare professional based on the severity of the infection and the patient's response to treatment. It is typically applied one or two times a day after cleaning the infected area. The treatment duration is usually limited to one week, but this may vary depending on the individual's condition.

Fusidate De Sodium Pierre Fabre can be used during pregnancy and breastfeeding, but it should be done under the supervision of a healthcare professional. The medication is applied topically, and systemic absorption is minimal. However, it is important to consult with a doctor to ensure the benefits outweigh any potential risks, especially during pregnancy.

To order Fusidate De Sodium Pierre Fabre from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask you to confirm your trade or institutional credentials and will then provide pricing, availability, shipping details, and the necessary import paperwork.

Fusidate De Sodium Pierre Fabre is a topical antibiotic specifically effective against staphylococci and streptococci. Compared to other topical antibiotics, it has a narrow spectrum of activity, making it suitable for specific bacterial infections. Its bacteriostatic effect makes it effective in treating localized skin infections without the risk of systemic side effects associated with oral antibiotics.

Fusidate De Sodium Pierre Fabre should be stored below 25°C, in the original pack, and protected from moisture. It is important to keep the medication out of reach of children and to avoid contact with eyes, mouth, and open wounds unless directed by a healthcare professional. Proper storage ensures the medication's effectiveness and safety.

Fusidate De Sodium Pierre Fabre is administered topically. The affected area should be cleaned before applying the pommade. The medication is applied in a thin layer one or two times a day, depending on the healthcare professional's instructions. It can be used with or without a bandage, but it is important to avoid applying it in thick layers.

The most serious risks associated with Fusidate De Sodium Pierre Fabre include allergic reactions, such as urticaria and angioedema, and severe skin reactions, such as blistering or rash. If any of these symptoms occur, the medication should be discontinued immediately, and medical attention should be sought. It is also important to avoid contact with the eyes, as it may cause conjunctivitis or irritation.

Fusidate De Sodium Pierre Fabre should not be used by individuals who are allergic to sodium fusidate or any of the other ingredients in the medication. It should also not be applied to large skin areas, especially in infants, or on weeping, macerated lesions, skin folds, or leg ulcers. Patients with a history of severe allergic reactions to antibiotics should consult a healthcare professional before using this medication.